Congenital Hypothyroidism With Eutopic Thyroid Gland: Analysis of Clinical and Biochemical Features at Diagnosis and After Re-Evaluation
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
CONTEXT: In recent years changes in screening strategies for congenital hypothyroidism (CH) led to an increased detection of mild forms of CH, associated with eutopic thyroid gland. OBJECTIVES: We aimed to determine the clinical evolution of CH with eutopic thyroid gland and to find out prognostic factors at diagnosis and follow-up. PATIENTS AND METHODS: We retrospectively analyzed a group of 84 children with CH and eutopic thyroid gland treated at our institution. They all underwent clinical re-evaluation after the age of 3, based on thyroid function testing after l-thyroxine therapy withdrawal, thyroid ultrasonography, and (123)I scintigraphy with perchlorate discharge test. Genetic analysis was performed in selected cases. RESULTS: At re-evaluation, 34.5% of patients showed permanent hypothyroidism and needed l-thyroxine reintroduction, 27.4% had persistent hyperthyrotropinemia (TSH 5-10 mU/L), and 38.1% had transient hypothyroidism. Major risk factors for permanent CH were prematurity, first-degree familial history of goiter/nodules, thyroid hypoplasia at diagnosis, and high l-thyroxine requirements at follow-up. Iodine organification defects were found in 29.7% of patients, 30% of whom harbored DUOX2 mutations. TSH receptor gene mutations were found in 8.7% of patients with persistent thyroid dysfunction and negative perchlorate discharge test. CONCLUSIONS: Only one-third of patients with CH and eutopic thyroid gland needed to continue l-thyroxine therapy after re-evaluation. A frequent finding was the persistence of mild hyperthyrotropinemia. The evolution of CH remains difficult to predict, although different clinical features might suggest different outcomes. Mutations in the genes commonly linked to mild forms of CH were documented in a minority of cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, factors such as prematurity (11,142,143), other congenital abnormalities (141), a family history of thyroid disease (142), abnormal thyroid morphology (thyroid hypoplasia at diagnosis) (142), TSH elevation >10 mU/L after the age of 1 year (when infants outgrow the LT4 dose), and a higher LT4 dose requirement at 1 to 3 years of age are associated with permanent CH”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Update of Newborn Screening and Therapy for Congenital Hypothyroidism
American Academy of Pediatrics, Rose, S. R., and the Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown, R. S., and the Public Health Committee, & Lawson Wilkins Pediatric Endocrine Society (2006) · Pediatrics · doi:10.1542/peds.2006-0915 · Cited by 798
Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485
Increase in congenital hypothyroidism in New York State and in the United States
Harris, K. B., & Pass, K. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.03.012 · Cited by 270 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundCorbetta, C., Weber, G., Cortinovis, F., Calebiro, D., Passoni, A., Vigone, M. C., Beck‐Peccoz, P., Chiumello, G., & Persani, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03568.x · Cited by 247 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundSelf-citationDeladoëy, J., Ruel, J., Giguère, Y., & Van Vliet, G. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1073 · Cited by 235
Grosse, S. D., & Van Vliet, G. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.190280 · Cited by 222
Hinton, C. F., Harris, K. B., Borgfeld, L., Drummond-Borg, M., Eaton, R., Lorey, F., Therrell, B. L., Wallace, J., & Pass, K. A. (2010) · Pediatrics · doi:10.1542/peds.2009-1975d · Cited by 207
Mengreli, C., Kanaka-Gantenbein, C., Girginoudis, P., Magiakou, M.-A., Christakopoulou, I., Giannoulia-Karantana, A., Chrousos, G. P., & Dacou-Voutetakis, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0057 · Cited by 146 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundGaudino, R., Garel, C., Czernichow, P., & Léger, J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02239.x · Cited by 138
Research works printed but not linked: 1
- 15. KrudeH,BlankensteinO. Treatingpatientsnotnumbers:thebenefit and burden of lowering TSH newborn screening cut-offs. Arch Dis Child . 2011;96:121-122.
Cited by
Items 101–135 of 135
Endocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cassio, A., Cicognani, A., & Boldrini, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-18159-2_259-1 · Cited by 3
Peters, C. J., & Schoenmakers, N. A. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch8 · Cited by 3
Prediction of Transient or Permanent Congenital Hypothyroidism
Evin, F., Balkı, H. G., Ata, A., Er, E., VATANSEVER, Z., Özen, S., Gökşen, D., & Darcan, Ş. (2022) · The Journal of Pediatric Research · doi:10.4274/jpr.galenos.2021.55707 · Cited by 3
“However, the TSH levels and L-T4 doses were not statistically significant higher in the P-CH group as was seen in several other studies (6,18).”
ResultSun, F., Wan, J.-P., Zhang, H., Nulali, J., Fang, Y., Zhang, Q.-Y., Wu, C., Wu, F.-Y., Zhang, Q.-Y., Yang, R.-M., et al. (2025) · Thyroid · doi:10.1177/10507256251372195 · Cited by 2
“Of 27 patients with adequate follow-up after suspension of LT4 therapy (the median duration of follow-up was 17.5 months [interquartile range: 8.5, 29.25]), 6 patients presented serum TSH concentration > 10 l IU/mL at least once within 6 months of withdrawal, and they were classi fi ed as PCH.”
InfluentialMorphometric features of the fetal thyroid gland: ultrasound examination findings
Murtazina, N. I., Луцай, Е. Д., & Саренко, А. А. (2020) · Journal of Anatomy and Histopathology · doi:10.18499/2225-7357-2020-9-3-35-41 · Cited by 2
Pignata, L., Bagattini, B., Cosmo, C. D., Agretti, P., Marco, G. D., Ferrarini, E., Montanelli, L., & Tonacchera, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae471 · Cited by 2
The natural course of newborns with transient congenital hypothyroidism
Almagor, T., Almashanu, S., Elias-Assad, G., Admoni, O., Ludar, H., London, S., Rath, S. R., German, A., Schwartz, N., & Tenenbaum‐Rakover, Y. (2024) · Endocrine Connections · doi:10.1530/ec-24-0316 · Cited by 2
“…13, 14, 15, 16, 17, 18, 19, 21, 24) and higher FT4 levels at diagnosis (14, 15, 28), lower LT4 requirements (12, 13, 14, 15, 16, 18, 21, 22, 23, 24, 26, 27, 28, 29), lack of TSH elevation during treatment (18), low birth weight (21, 23, 25, 30), non-white ethnicity (30), male gender (21),…”
van Gisbergen, M., de Moor, R. A., Stuart, A. A. V., van den Berg, G., Sijbesma, B., & van Hoften, J. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-262474 · Cited by 2
“…et al 24 studied 3137 preterm newborns born between 22–31 weeks of gestation and found dTSH in 45/49 newborns diagnosed with CH. Rabbiosi et al 25 and Vigone et al 26 found permanent CH at clinical re-evaluation after withdrawal of levothyroxine in respectively 35% and 24% of their studied…”
Fuyong, J. (2015) · International Journal of Clinical Endocrinology and Metabolism · doi:10.17352/ijcem.000005 · Cited by 2
Norman, A. W., & Henry, H. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-08-091906-5.00005-7 · Cited by 2
Lamichhane, T. R., Pant, S. P., Lamichhane, B., Paudel, S., Yadav, B. K., & Lamichhane, H. P. (2022) · BIOPHYSICS · doi:10.1134/s0006350922020130 · Cited by 1
Iatrogenic hyperthyroidism in primary congenital hypothyroidism: prevalence and predictive factors
Chooprasertsuk, N., Dejkhamron, P., Unachak, K., & Wejaphikul, K. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0152 · Cited by 1
Nalbantoğlu, Ö., & Özkan, B. (2022) · Journal of Dr Behcet Uz Children s Hospital · doi:10.4274/buchd.galenos.2022.75418 · Cited by 1
Who needs thyroid function testing at birth?
Cheetham, T. D., & Lane, L. C. (2016) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-310548 · Cited by 1
Gumes-Felix, H. M., Ramalho, R. J. R., de Melo, E. V., de Matos, D. M., Menezes, N. V., Oliveira, C. R. P., Campos, V. C., Santos, E. G., Marques, D. D. S., dos Santos, B. V., et al. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000579 · Cited by 2
“This finding agrees with several previously published reports (12,17,23).”
BackgroundResultPark, J., Joo, E. Y., Yoo, M. J., Kim, S. J., Jang, W., & Lee, J. E. (2024) · Medicine · doi:10.1097/md.0000000000038976 · Cited by 1
“…time of diagnosis alone cannot predict the prognosis of patients with CHT, including whether they will transition to permanent or transient CHT. [23,24] In real clinical scenarios, clinicians frequently encounter the dilemma of determining the duration for which they should continue prescribing LT…”
BackgroundKara, C., & Korkmaz, H. A. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-4-15 · Cited by 1
Predicting variables associated with diagnostic reevaluation of transient congenital hypothyroidism
Gwag, S.-H., Park, K. H., Kang, E., Nam, H., Rhie, Y., & Lee, K. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2448164.082 · Cited by 1
“In contrast, other studies have reported that TSH levels at diagnosis do not seem to be helpful in predicting TCH [19,26].”
Congenital Hypothyroidism: Screening, Early Management, and Outcome
Cheetham, T. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65359-x · Cited by 1
Tanyeri, D., Anık, A., Cengiz, A. K., Polat, Y. D., Ünüvar, T., & Anık, A. (2021) · The Journal of Pediatric Research · doi:10.4274/jpr.galenos.2020.68736 · Cited by 1
“63 (4-51) days and the rate of diagnosis in the first month was 88.”
BackgroundResultSilvestrin, S. M. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-14082014-085542 · Cited by 1
Role of thyrotropin‐releasing hormone test in re‐evaluation of congenital hypothyroidism
Chen, L., Chen, Y., Hsiao, H., Chen, B., & Chao, M. (2014) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2014.04.005
“The current study excluded the patients with thyroid agenesis and ectopia, and around one-third of those with eutopic thyroid glands needed lifelong levothyroxine treatment, which is consistent with a previous report [15].”
ResultManaging Hypothyroidism in Pediatric Patients
LAFRANCHI, S. H. (2018) · US Endocrinology · doi:10.17925/use.2018.14.2.51
“7%) with congenital hypothyroidism and thyroid gland in situ had iodide organification defects based on positive perchlorate discharge tests.(8) Of those with partial organification defects, 30% had mutations of DUOX2.”
BackgroundThyroid Hormones-Thyrotropin Interrelationships in Thyroid Dysfunction StatesPreprint
Lamichhane, T. R., Pant, S. P., Lamichhane, B., Paudel, S., Yadav, B. K., & Lamichhane, H. P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.26.173252
Cosmo, C. D., & Tonacchera, M. (2018) · Endocrinology · doi:10.1007/978-3-319-29195-6_11-1
Endocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cassio, A., Cicognani, A., & Boldrini, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-18159-2_259-2
Bauer, A. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-69415-5.00026-6
Update in Pediatric Endocrinology
Marks, S. D., & Wicklow, B. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-41542-5_14
Aldhalemi, A. A., & Lahhob, Q. R. (2024) · International Journal of Chemical and Biological Sciences · doi:10.33545/26646765.2024.v6.i1a.71
Congenital hypothyroidism: Screening, early management and outcome
Cheetham, T. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00241-7
Cosmo, C. D., Pignata, L., Bagattini, B., Agretti, P., Marco, G. D., Ferrarini, E., Santini, F., Montanelli, L., & Tonacchera, M. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02718-x
Salerno, M., Vigone, M. C., Cassio, A., Cavarzere, P., Cherubini, V., Faienza, M. F., Gastaldi, R., Tuli, G., Wasniewska, M. G., & Olivieri, A. (2026) · Endocrine · doi:10.1007/s12020-026-04656-x
Self-citationClinical and genetic insights into congenital hypothyroidism with gland-in-situ
Dursun, F., Eser, M., Yarar, M. H., Sargin, I. D., Yaşar, A., Altun, E. E., Atmaca, F. G., Ulu, Ş. E., & Kırmızıbekmez, H. (2026) · Trends in Pediatrics · doi:10.59213/tp.2026.394
“14 Rabbiosi et al. have shown that thyroid hypoplasia on US was correlated with PCH, and that no patients with hypoplastic thyroid harbored TCH. 16 Our study showed that heterozygous variants can cause hypoplastic gland and suggested that although the variant is heterozygous, having a hypoplastic thyroid gland is more…”
Pavone, P., Verrotti, A., Dell’Isola, G. B., Avola, O., Bianco, M. L., Giaimi, M., Nora, A. D., Ferrara, P., & Timpanaro, T. (2025) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v96i2.15544
Tailored approach to pediatric patients affected by congenital hypothyroidism
Tuli, G. (n.d.) · Institutional Research Information System University of Turin (University of Turin)
Metadata
- Authors
- Rabbiosi, S., Vigone, M. C., Cortinovis, F., Zamproni, I., Fugazzola, L., Persani, L., Corbetta, C., Chiumello, G., & Weber, G.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Department of Pediatrics (S.R., M.C.V., F.C., G.C., G.W.), 20132 Milan, Italy
- University of Milan (IT)
- Ospedale dei Bambini Vittore Buzzi (IT)
- Corresponding author
- Rabbiosi, Sarah
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-04-01
- Volume
- 98
- Issue
- 4
- Pages
- 1395-1402
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2051249595
- Cited by
- 131
- References
- 31
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 11 · 2018: 16 · 2017: 8 · 2016: 12 · 2015: 9 · 2014: 16 · 2013: 4
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Regione Lombardia
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Head and Neck Anomalies
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- congenital hypothyroidism, transient hypothyroidism, permanent hypothyroidism, hyperthyrotropinemia, TSH receptor mutations, preterm birth, thyroid hypoplasia, prognostic factors, thyroid function tests, thyroid ultrasound
- MeSH terms
- Child, Child, Preschool, Congenital Hypothyroidism, Female, Follow-Up Studies, Humans, Infant, Newborn, Infant, Premature, Male, Prognosis, Retrospective Studies, Thyroid Function Tests, Thyroid Gland, Thyroxine, Ultrasonography, Cohort Studies, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.